153 related articles for article (PubMed ID: 24096836)
21. Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons.
Mongeau R; Weiss M; de Montigny C; Blier P
Neuropharmacology; 1998 Jul; 37(7):905-18. PubMed ID: 9776386
[TBL] [Abstract][Full Text] [Related]
22. Clonidine inhibits itch-related response through stimulation of α(2)-adrenoceptors in the spinal cord in mice.
Gotoh Y; Andoh T; Kuraishi Y
Eur J Pharmacol; 2011 Jan; 650(1):215-9. PubMed ID: 20951695
[TBL] [Abstract][Full Text] [Related]
23. Electroacupuncture Enhances the Antiallodynic and Antihyperalgesic Effects of Milnacipran in Neuropathic Rats.
Li C; Ji BU; Kim Y; Lee JE; Kim NK; Kim ST; Koo S
Anesth Analg; 2016 May; 122(5):1654-62. PubMed ID: 26962713
[TBL] [Abstract][Full Text] [Related]
24. Milnacipran, a serotonin and norepinephrine reuptake inhibitor, induces appetite-suppressing effects without inducing hypothalamic stress responses in mice.
Nonogaki K; Nozue K; Kuboki T; Oka Y
Am J Physiol Regul Integr Comp Physiol; 2007 May; 292(5):R1775-81. PubMed ID: 17218444
[TBL] [Abstract][Full Text] [Related]
25. Subchronic milnacipran treatment increases basal extracellular noradrenaline concentrations in the medial prefrontal cortex of rats.
Kitaichi Y; Inoue T; Izumi T; Nakagawa S; Kato A; Koyama T
Eur J Pharmacol; 2005 Sep; 520(1-3):37-42. PubMed ID: 16153636
[TBL] [Abstract][Full Text] [Related]
26. Repeated administration of milnacipran induces rapid desensitization of somatodendritic 5-HT1A autoreceptors but not postsynaptic 5-HT1A receptors.
Mochizuki D; Hokonohara T; Kawasaki K; Miki N
J Psychopharmacol; 2002 Sep; 16(3):253-60. PubMed ID: 12236634
[TBL] [Abstract][Full Text] [Related]
27. Effects of repeated milnacipran administration on brain serotonergic and noradrenergic functions in healthy volunteers.
Soya A; Terao T; Nakajima M; Kojima H; Okamoto T; Inoue Y; Iwakawa M; Shinkai K; Yoshimura R; Ueta Y; Nakamura J
Psychopharmacology (Berl); 2006 Sep; 187(4):526-7. PubMed ID: 16830129
[No Abstract] [Full Text] [Related]
28. Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain.
Leo RJ; Brooks VL
Curr Opin Investig Drugs; 2006 Jul; 7(7):637-42. PubMed ID: 16869117
[TBL] [Abstract][Full Text] [Related]
29. Modulation of the extracellular 5-hydroxytryptamine brain concentrations by the serotonin and noradrenaline reuptake inhibitor, milnacipran. Microdialysis studies in rats.
Bel N; Artigas F
Neuropsychopharmacology; 1999 Dec; 21(6):745-54. PubMed ID: 10633480
[TBL] [Abstract][Full Text] [Related]
30. Effects of milnacipran on the inhibitory postsynaptic potential in neurons of the rat locus coeruleus.
Kuwahata T; Kidani Y; Ishimatsu M; Akasu T
Kurume Med J; 2004; 51(3-4):185-91. PubMed ID: 15682825
[TBL] [Abstract][Full Text] [Related]
31. Tonic inhibition of allergic itch signaling by the descending noradrenergic system in mice.
Gotoh Y; Omori Y; Andoh T; Kuraishi Y
J Pharmacol Sci; 2011; 115(3):417-20. PubMed ID: 21372505
[TBL] [Abstract][Full Text] [Related]
32. alpha2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice.
Massé F; Hascoët M; Bourin M
Behav Brain Res; 2005 Oct; 164(1):17-28. PubMed ID: 16081166
[TBL] [Abstract][Full Text] [Related]
33. Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action.
Bourin M; Masse F; Dailly E; Hascoët M
Pharmacol Biochem Behav; 2005 Jul; 81(3):645-56. PubMed ID: 15961146
[TBL] [Abstract][Full Text] [Related]
34. Serotonin and noradrenaline reuptake inhibitors in animal models of pain.
Mochizucki D
Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S15-9. PubMed ID: 15378668
[TBL] [Abstract][Full Text] [Related]
35. Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats.
Saitoh A; Yamaguchi K; Tatsumi Y; Murasawa H; Nakatani A; Hirose N; Yamada M; Yamada M; Kamei J
Psychopharmacology (Berl); 2007 May; 191(4):857-65. PubMed ID: 17318509
[TBL] [Abstract][Full Text] [Related]
36. The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid model of impulsive action using rats.
Tsutsui-Kimura I; Ohmura Y; Izumi T; Yamaguchi T; Yoshida T; Yoshioka M
Behav Pharmacol; 2009 Sep; 20(5-6):474-83. PubMed ID: 19730368
[TBL] [Abstract][Full Text] [Related]
37. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
Rénéric JP; Bouvard M; Stinus L
Neuropsychopharmacology; 2001 Apr; 24(4):379-90. PubMed ID: 11182533
[TBL] [Abstract][Full Text] [Related]
38. Milnacipran affects mouse impulsive, aggressive, and depressive-like behaviors in a distinct dose-dependent manner.
Tsutsui-Kimura I; Ohmura Y; Yoshida T; Yoshioka M
J Pharmacol Sci; 2017 Jul; 134(3):181-189. PubMed ID: 28694090
[TBL] [Abstract][Full Text] [Related]
39. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
Vaishnavi SN; Nemeroff CB; Plott SJ; Rao SG; Kranzler J; Owens MJ
Biol Psychiatry; 2004 Feb; 55(3):320-2. PubMed ID: 14744476
[TBL] [Abstract][Full Text] [Related]
40. Effect of milnacipran and desipramine on noradrenergic alpha 2-autoreceptor sensitivity.
Moret C; Briley M
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Oct; 18(6):1063-72. PubMed ID: 7824760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]